University of Münster
CRIS@UM
DE | EN

Franziska Rodner

Current affiliations

  • Institute of Molecular Virology

Publications

The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance.
Schreiber A; Rodner F; Oberberg N; Anhlan D; Bletz S; Mellmann A; Planz O; Ludwig S (2024)
In: Antiviral Research, 225
Type of Publication: Research article (journal)